Format

Send to

Choose Destination
Hum Vaccin Immunother. 2012 Jun;8(6):823-7. doi: 10.4161/hv.20042. Epub 2012 Jun 1.

Hepatitis E vaccine development: a 14 year odyssey.

Author information

1
National Institute of Diagnostics and Vaccine Development in Infectious Diseases, Xiamen University, Xiamen, China.

Abstract

The first prophylactic vaccine, HecolinĀ®, against hepatitis E virus (HEV) infection and the HEV associated disease was approved by China's State Food and Drug Administration (SFDA) in December 2011. Key milestones during the 14-year HEV vaccine development are summarized in this commentary.Ā  After years of innovative research the recombinant virus-like particle (VLP) based antigen with virion-like epitopes was successfully produced in E. coli production platform on a commercial scale. Safety and efficacy of this vaccine was demonstrated in a large scale phase III clinical trial.

PMID:
22699438
DOI:
10.4161/hv.20042
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center